COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 796: Articles 7951-7960  | Next

Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatus
Michielin, G., Arefi, F., Puhach, O., Bellon, M., Sattonnet, P., L'Huillier, A., Eckerle, I., Meyer, B., Maerkl, S. J.
10.1101/2022.06.09.22276142 — Posted: 2022-06-14
Baseline Peripheral Blood Counts and Outcomes in Patients Presenting with COVID-19
Jeyaraman, P., Borah, P., Singh, O., Dewan, A., Dayal, N., Naithani, R.
10.1101/2022.06.10.22276256 — Posted: 2022-06-14
The evolving scenario of COVID-19 in hemodialysis patients
Esposito, P., Picciotto, D., Cappadona, F., Russo, E., Falqui, V., Conti, N. E., Parodi, A., Mallia, L., Cavagnaro, S., Battaglia, Y., Viazzi, F.
10.1101/2022.06.09.22276185 — Posted: 2022-06-14
Kidney patients remain at increased risk for succumbing to COVID-19
Hendrickx, R., Jellingso, M., Sommer, M. O. A.
10.1101/2022.06.12.22276220 — Posted: 2022-06-14
Neutralising antibodies predict protection from severe COVID-19
Cromer, D., Steain, M., Reynaldi, A., Schlub, T. E., Sasson, S. C., Kent, S. J., Khoury, D. S., Davenport, M. P.
10.1101/2022.06.09.22275942 — Posted: 2022-06-14
Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: genome-wide cross trait analysis and bi-directional Mendelian randomization study
Yao, M., Wang, X., Guo, Y., Zhao, J. V., Liu, Z.
10.1101/2022.06.10.22276268 — Posted: 2022-06-14
The prevalence of mental ill-health in women during pregnancy and after childbirth during the Covid-19 pandemic: a Systematic review and Meta-analysis
Delanerolle, G., McCauley, M., Hirsch, M., Zeng, Y., Cong, X., Cavalini, H., Shetty, A., rathod, s., Shi, J. Q., Hapangama, D. K., Phiri, P.
10.1101/2022.06.13.22276327 — Posted: 2022-06-14
Pediatric ARDS phenotypes in critical COVID-19: implications for therapies and outcomes.
Dominguez Rojas, J. A., Luna-Delgado, Y., Caqui-Vilca, P., Martel Ramirez, C., Quispe Chipana, M., Cruz-Arpi, M., Atamari-Anahui, N., Munoz Ramirez, C. M., Quispe Flores, G., Tello Pezo, M., Cruces, P., Vasquez-Hoyos, P., DIAZ, F.
10.1101/2022.06.08.22276125 — Posted: 2022-06-14
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States
Adams, K., Rhoads, J. P., Surie, D., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Huynh, D., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A., Shapiro, N. I., Gibbs, K. W., Files, D. C., Hicks, M., Hager, D. N., Ali, H., Prekker, M. E., Frosch, A. E., Exline, M. C., Gong, M. N., Mohamed, A., Johnson, N. J., Srinivasan, V., Steingrub, J. S., Peltan, I. D., Brown, S. M., Martin, E. T., Monto, A. S., Lauring, A. S., Khan, A., Hough, C. L., Busse, L. W., ten Lohuis, C. C., Duggal, A., Wilson, J. G., Gordon, A. J., Qadir, N., Chang, S. Y., Mallow, C., Rivas, C., Babcock, H. M., Kwon, J. H., Chappell, J. D., Halasa, N., Grijalva, C. G., Rice, T. W., Stubblefield, W. B., Baughman, A., Lindsell, C. J., Hart, K. W., Lester, S. N., Thornburg, N. J., Park, S., McMorrow, M. L., Patel, M. M., Tenforde, M. W., Self, W. H.
10.1101/2022.06.09.22276228 — Posted: 2022-06-14
Is age the most important risk factor in COVID-19 patients? The relevance of comorbidity burden: A retrospective analysis of 10,090 hospitalizations
Valero, D., Monterde, D., Carot-Sans, G., Cainzos-Achirica, M., Comin-Colet, J., Vela, E., Cleries, M., Abilleira, S., Arrufat, M., Lejardi, Y., Solans, O., Dedeu, T., Coca, M., Perez-Sust, P., Piera-Jimenez, J.
10.1101/2022.06.14.22276380 — Posted: 2022-06-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).